| 688065 Stock | | | 49.79 1.11 2.28% |
Cathay Biotech financial indicator trend analysis is way more than just evaluating Cathay Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cathay Biotech is a good investment. Please check the relationship between Cathay Biotech Non Currrent Assets Other and its Accounts Payable accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Non Currrent Assets Other vs Accounts Payable
Non Currrent Assets Other vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cathay Biotech Non Currrent Assets Other account and
Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Cathay Biotech's Non Currrent Assets Other and Accounts Payable is 0.47. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Cathay Biotech, assuming nothing else is changed. The correlation between historical values of Cathay Biotech's Non Currrent Assets Other and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Cathay Biotech are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Non Currrent Assets Other i.e., Cathay Biotech's Non Currrent Assets Other and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.47 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Accounts Payable
An accounting item on the balance sheet that represents Cathay Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cathay Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Cathay Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The current year's
Tax Provision is expected to grow to about 56.8
M, whereas
Selling General Administrative is forecasted to decline to about 83.2
M.
Cathay Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Cathay Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cathay Biotech fundamental ratios Accounts
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Balance Sheet is a snapshot of the
financial position of Cathay Biotech at a specified time, usually calculated after every quarter, six months, or one year. Cathay Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cathay Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cathay currently owns. An asset can also be divided into two categories, current and non-current.